# Novo Holdings A/S's Biotech Investments: 21 Startups in Its Portfolio (2026) > The 21 Biotech startups Novo Holdings A/S has backed, by stage: $1.8B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/novo-holdings-a-s-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series A 6 - [Disc Medicine](https://millionrounds.com/company/disc-medicine) - [*MT* Mirum Therapeutics](https://millionrounds.com/company/mirum-therapeutics) - [Hillstar Bio](https://millionrounds.com/company/hillstar-bio) - [*DT* Delenex Therapeutics](https://millionrounds.com/company/delenex-therapeutics) - [Coave Therapeutics](https://millionrounds.com/company/coave-therapeutics) - [Outpost Medicine](https://millionrounds.com/company/outpost-medicine) ## Series C and later 6 - [Procept BioRobotics](https://millionrounds.com/company/procept-biorobotics) - [Glycomine](https://millionrounds.com/company/glycomine) - [*ST* Synosia Therapeutics](https://millionrounds.com/company/synosia-therapeutics) - [CellBiosciences](https://millionrounds.com/company/cellbiosciences) - [AnaptysBio](https://millionrounds.com/company/anaptysbio) - [*R* Rgenix](https://millionrounds.com/company/rgenix) ## Series B 6 - [Tarsa Therapeutics](https://millionrounds.com/company/tarsa-therapeutics) - [Lux Biosciences](https://millionrounds.com/company/lux-biosciences) - [*AT* Aristea Therapeutics](https://millionrounds.com/company/aristea-therapeutics) - [AlloCure](https://millionrounds.com/company/allocure) - [*NT* Nora Therapeutics](https://millionrounds.com/company/nora-therapeutics) - [*KT* Karus Therapeutics](https://millionrounds.com/company/karus-therapeutics) ## Stage not reported 3 - [SI-BONE](https://millionrounds.com/company/si-bone) - [MediQuest Therapeutics](https://millionrounds.com/company/mediquest-therapeutics) - [*PP* Panacos Pharmaceuticals](https://millionrounds.com/company/panacos-pharmaceuticals) ## Segment by segment ### Series A 6 startups · $556M raised - [**Disc Medicine**](https://millionrounds.com/company/disc-medicine) Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders. United States $275M - [*MT* **Mirum Therapeutics**](https://millionrounds.com/company/mirum-therapeutics) United States $120M - [**Hillstar Bio**](https://millionrounds.com/company/hillstar-bio) Hillstar Bio is a Boston-based biotechnology company founded in 2023, specializing in precision immunology. United States $67M - [*DT* **Delenex Therapeutics**](https://millionrounds.com/company/delenex-therapeutics) Delenex Therapeutics is engaged in developing therapeutic antibody fragments for diseases with high unmet needs. Switzerland $41M - [**Coave Therapeutics**](https://millionrounds.com/company/coave-therapeutics) Horama develops gene therapies for rare inherited ocular and CNS (central nervous system) diseases. France $33M - [**Outpost Medicine**](https://millionrounds.com/company/outpost-medicine) Outpost Medicine is a biopharmaceutical company United Kingdom $20M ### Series C and later 6 startups · $712M raised - [**Procept BioRobotics**](https://millionrounds.com/company/procept-biorobotics) PROCEPT BioRobotics is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. United States $210M - [**Glycomine**](https://millionrounds.com/company/glycomine) Glycomine is an early-stage biotech working on replacement therapies for rare diseases. United States $160M - [*ST* **Synosia Therapeutics**](https://millionrounds.com/company/synosia-therapeutics) Synosia Therapeutics develops and commercializes products for unmet medical needs in psychiatry and neurology. Switzerland $92M - [**CellBiosciences**](https://millionrounds.com/company/cellbiosciences) ProteinSimple develops and commercializes proprietary systems and consumables for protein analyzis. United States $85M - [**AnaptysBio**](https://millionrounds.com/company/anaptysbio) AnaptysBio ($ANAB) is a clinical-stage biotechnology company focused on transforming patient health by discovering and developing United States $85M - [*R* **Rgenix**](https://millionrounds.com/company/rgenix) United States $81M ### Series B 6 startups · $365M raised - [**Tarsa Therapeutics**](https://millionrounds.com/company/tarsa-therapeutics) Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis. United States $121M - [**Lux Biosciences**](https://millionrounds.com/company/lux-biosciences) Lux Biosciences is a biotechnology company developing medicines for the treatment of ophthalmic diseases. United States $90M - [*AT* **Aristea Therapeutics**](https://millionrounds.com/company/aristea-therapeutics) Aristea Therapeutics is a developer of novel therapies created for autoimmune diseases. United States $78M - [**AlloCure**](https://millionrounds.com/company/allocure) AlloCure is a clinical-stage biotechnology company based in Burlington, Massachusetts, specializing in cell therapies for kidney d United States $47M - [*NT* **Nora Therapeutics**](https://millionrounds.com/company/nora-therapeutics) Nora develops therapeutics to address unmet clinical needs in reproductive medicine. United States $21M - [*KT* **Karus Therapeutics**](https://millionrounds.com/company/karus-therapeutics) Karus Therapeutics is a pharmaceutical research company that develops drugs to treat cancer and heart diseases. United Kingdom $7.6M ### Stage not reported 3 startups · $184M raised - [**SI-BONE**](https://millionrounds.com/company/si-bone) SI-BONE advances the diagnostic understanding of lower back pain and minimally invasive surgery for the sacroiliac joint. United States $102M - [**MediQuest Therapeutics**](https://millionrounds.com/company/mediquest-therapeutics) MediQuest Therapeutics is a pharmaceutical company providing topical solutions for inflammatory and infectious diseases. United States $44M - [*PP* **Panacos Pharmaceuticals**](https://millionrounds.com/company/panacos-pharmaceuticals) Panacos Pharmaceuticals a drug company focused on HIV and other major human viral diseases. United States $38M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Novo Holdings A/S as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **SBI Group's Fintech portfolio** 10 startups · $724M](https://millionrounds.com/portfolio-maps/sbi-group-fintech-portfolio)[Sector portfolio **Johnson & Johnson Innovation's Biotech portfolio** 10 startups · $1.4B](https://millionrounds.com/portfolio-maps/johnson-and-johnson-innovation-biotech-portfolio)[Sector portfolio **Y Combinator's AI portfolio** 1,143 startups · $44B](https://millionrounds.com/portfolio-maps/y-combinator-ai-portfolio)[Sector portfolio **Y Combinator's Fintech portfolio** 338 startups · $24B](https://millionrounds.com/portfolio-maps/y-combinator-fintech-portfolio)[Sector portfolio **Techstars' AI portfolio** 336 startups · $4.9B](https://millionrounds.com/portfolio-maps/techstars-ai-portfolio)[Sector portfolio **Alumni Ventures' AI portfolio** 302 startups · $36B](https://millionrounds.com/portfolio-maps/us-strategic-tech-fund-an-alumni-ventures-fund-ai-portfolio) ## Raising from investors like Novo Holdings A/S? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)